RSM logo
Obstetric Medicine

Home Current issue Browse archive Alerts About the journal Feedback
 
Obstet Med 2009;2:34-37
doi:10.1258/om.2008.080046
© 2009 Royal Society of Medicine Press

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Al-Ozairi, E
Right arrow Articles by Taylor, R
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Case reports

Termination is not the treatment of choice for severe hyperemesis gravidarum: Successful management using prednisolone

E Al-Ozairi MBChB MRCP   *, J J S Waugh MBBS MRCOG   {dagger} and R Taylor MD FRCP   * 

* Directorates of Medicine; {dagger} Directorate of Obstetrics, Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne NE1 4LP, UK

Correspondence to: Professor Roy Taylor Email: roy.taylor{at}ncl.ac.uk

Severe hyperemesis gravidarum causes profound maternal morbidity. Termination of pregnancy is still offered before the use of medical therapy. This report describes management of a woman who had undergone two previous terminations for hyperemesis, and additionally presents the dosage profile of prednisolone used to successfully manage a consecutive series of 33 women with severe hyperemesis gravidarum. The treatment protocol is described. The group had a median weight loss in pregnancy of 5.5 kg (range 2.0–12.5 kg), had been admitted on a median of 3.0 (range 0–9) occasions and had spent 7.5 (range 0–25) days on i.v. fluids. Continuing vomiting prevented oral steroid therapy in 14 women and i.v. hydrocortisone (50 mg t.i.d.; two women required 100 mg t.i.d.) was used initially for 24–48 h. Nineteen women commenced prednisolone 10 mg t.i.d. and this achieved suppression of vomiting within 48 h in all but two women who required 15 mg t.i.d. Two distinct subtypes of hyperemesis gravidarum were identified. Remitting hyperemesis spontaneously ceases between 14 and 22 weeks gestation and accounts for approximately 80% of cases. In contrast, full-term hyperemesis persists until minutes after delivery. These separate sub-types have not previously been described. Steroid treatment of hyperemesis should be considered in women who fulfil the criteria of severe disease.

Key Words: hyperemesis • prednisolone • steroid therapy • vomiting • termination of pregnancy


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Obstet MedHome page
V J Heazlewood, M Ratnapala, and L Cochrane
Successful use of dexamethasone when prednisolone is not tolerated
Obstet Med, September 1, 2009; 2(3): 132 - 132.
[Full Text] [PDF]